IQVIA Safe Entry helps life sciences organizations decide where in-person HCP engagement is safe and effective in the context of COVID-19. Using weekly refreshed KPIs such as new COVID-19 cases, new-to-brand prescription trends, and telemedicine activity, it generates heat maps that classify territories for in-person promotion, remote engagement, or consideration. User-defined rules allow “what-if” simulations to support sales force re-entry planning. The turnkey solution is customized to market interests, territory alignments, and engagement rules, simplifying complex decisions while maximizing engagement and ensuring field force safety.

Join for free to read